Free Trial

Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Jupiter Asset Management Ltd.

Mettler-Toledo International logo with Medical background
Remove Ads

Jupiter Asset Management Ltd. decreased its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 11.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 31,917 shares of the medical instruments supplier's stock after selling 4,239 shares during the period. Jupiter Asset Management Ltd. owned about 0.15% of Mettler-Toledo International worth $39,056,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Farther Finance Advisors LLC grew its holdings in Mettler-Toledo International by 14.3% in the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock valued at $78,000 after purchasing an additional 8 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in Mettler-Toledo International by 28.8% in the fourth quarter. EverSource Wealth Advisors LLC now owns 152 shares of the medical instruments supplier's stock valued at $186,000 after purchasing an additional 34 shares during the last quarter. Sequoia Financial Advisors LLC grew its holdings in Mettler-Toledo International by 10.4% in the fourth quarter. Sequoia Financial Advisors LLC now owns 616 shares of the medical instruments supplier's stock valued at $753,000 after purchasing an additional 58 shares during the last quarter. Wealthfront Advisers LLC grew its holdings in Mettler-Toledo International by 4,357.4% in the fourth quarter. Wealthfront Advisers LLC now owns 35,258 shares of the medical instruments supplier's stock valued at $43,145,000 after purchasing an additional 34,467 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Mettler-Toledo International by 10.0% during the fourth quarter. Daiwa Securities Group Inc. now owns 5,205 shares of the medical instruments supplier's stock valued at $6,370,000 after acquiring an additional 472 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently commented on MTD. Citigroup decreased their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a "peer perform" rating on the stock. Evercore ISI increased their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research note on Monday, February 10th. Robert W. Baird increased their price objective on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Wells Fargo & Company increased their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an "equal weight" rating in a research note on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of "Hold" and an average target price of $1,380.50.

Remove Ads

Check Out Our Latest Analysis on MTD

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,243.20 on Wednesday. The stock's 50-day moving average is $1,295.68 and its 200-day moving average is $1,321.07. The company has a market cap of $26.00 billion, a price-to-earnings ratio of 30.67, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12 month low of $1,142.91 and a 12 month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the sale, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Christian Magloth sold 790 shares of the firm's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD - Free Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY NOW in March 2025

5 Stocks to BUY NOW in March 2025

MarketBeat's Thomas Hughes looks at five stocks poised for gains this year that investors should have on their watchlists for buying opportunities in March.

Related Videos

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads